Both AT1 and AT2 receptors mediate proliferation and migration of porcine vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Louis, Sherif ^a,b   Saward, Laura ^b   Zahradka, Peter ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Angiotensin II types 1 and 2 receptors; Focal adhesion kinase; Losartan; PD 123319; PF 573228

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CELL MARKER; FOCAL ADHESION KINASE; LOSARTAN; 6 (4 (3 (METHYLSULFONYL)BENZYLAMINO) 5 (TRIFLUOROMETHYL)PYRIMIDIN 2 YLAMINO) 3,4 DIHYDROQUINOLIN 2(1H) ONE; 6-(4-(3-(METHYLSULFONYL)BENZYLAMINO)-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YLAMINO)-3,4 -DIHYDROQUINOLIN-2(1H)-ONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; IMIDAZOLE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; QUINOLONE DERIVATIVE; SULFONE;

ANIMAL CELL; ARTICLE; BIOCHEMISTRY; CELL GROWTH; CELL HYPERPLASIA; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY; DNA SYNTHESIS; EPIFLUORESCENCE MICROSCOPY; EXPLANT; LIGAND BINDING; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; SMOOTH MUSCLE FIBER; WOUND HEALING; ANIMAL; CELL CULTURE; CELL MOTION; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; RNA INTERFERENCE; SWINE; TIME; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOCAL ADHESION PROTEIN-TYROSINE KINASES; IMIDAZOLES; LOSARTAN; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN KINASE INHIBITORS; PYRIDINES; QUINOLONES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SULFONES; SWINE; TIME FACTORS;

EID: 80052333339     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00431.2010     Document Type: Article

References (31)

1. Brillante DG, O'Sullivan AJ, Johnstone MT, Howes LG. Evidence for functional expression of vascular angiotensin II type 2 receptors in patients with insulin resistance. Diabetes Obes Metab 10: 143-150, 2008.
2. Cao Z, Dean R, Wu L, Casley D, Cooper ME. Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension 34: 408-414, 1999.
3. Chiu AT, Roscoe WA, McCall DE, Timmermans PB. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Receptor 1: 133-140, 1991.
4. Ferreira AJ, Santos RA, Bradford CN, Mecca AP, Sumners C, Katovich MJ, Raizada MK. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 55: 207-213, 2010.
5. Gilles R, Vingerhoedt N, Howes J, Griffin M, Howes LG. Increase in systemic blood pressure during intra-arterial PD123319 infusion: evidence for functional expression of angiotensin type 2 receptors in normal volunteers. Blood Press 13: 110-114, 2004.
6. Grigera PR, Jeffery ED, Martin KH, Shabanowitz J, Hunt DF, Parsons JT. FAK phosphorylation sites mapped by mass spectrometry. J Cell Sci 118: 4931-4935, 2005.
7. Halayko AJ, Camoretti-Mercado B, Forsythe SM, Vieira JE, Mitchell RW, Wylam ME, Hershenson MB, Solway J. Divergent differentiation paths in airway smooth muscle culture: induction of functionally contractile myocytes. Am J Physiol Lung Cell Mol Physiol 276: L197-L206, 1999.
8. Hunley TE, Tamura M, Stoneking BJ, Nishimura H, Ichiki T, Inagami T, Kon V. The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 null mutant mice. Kidney Int 57: 570-577, 2000.
9. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 120: 292-316, 2008.
10. Kambayashi Y, Nagata K, Ichiki T, Inagami T. Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular-smooth-muscle cells. Eur J Biochem 239: 558-565, 1996.
11. Li G, Jin R, Norris RA, Zhang L, Yu S, Wu F, Markwald RR, Nanda A, Conway SJ, Smyth SS, Granger DN. Periostin mediates vascular smooth muscle cell migration through the integrins alphanubeta3 and alphanubeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 208: 358-365, 2010.
12. Lietha D, Cai X, Ceccarelli DF, Li Y, Schaller MD, Eck MJ. Structural basis for the autoinhibition of focal adhesion kinase. Cell 129: 1177-1187, 2007.
13. Maione A, Strippoli GF. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the reninangiotensin system blockade. Ethn Dis 19: S1-86-89, 2009.
14. Moon MC, Yau L, Wright B, Zahradka P. Injury-induced expression of cytokeratins 8 and 18 by vascular smooth muscle cells requires concurrent activation of cytoskeletal and growth factor receptors. Can J Physiol Pharmacol 86: 223-231, 2008.
15. Nagashima H, Sakomura Y, Aoka Y, Uto K, Kameyama K, Ogawa M, Aomi S, Koyanagi H, Ishizuka N, Naruse M, Kawana M, Kasanuki H. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome. Circulation 104: I282-I287, 2001.
16. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92: 10663-10667, 1995.
17. Okuda M, Kawahara Y, Nakayama I, Hoshijima M, Yokoyama M. Angiotensin II transduces its signal to focal adhesions via angiotensin II type 1 receptors in vascular smooth muscle cells. FEBS Lett 368: 343-347, 1995.
18. Parsons JT, Slack-Davis J, Tilghman R, Roberts WG. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res 14: 627-632, 2008.
19. Renzetti AR, Barsacchi P, Catalioto RM, Criscuoli M, Mizrahi J. Differential effect of dithiothreitol and DuP 753 on angiotensin II receptor subtypes in bovine cerebellar cortex. Peptides 14: 1037-1041, 1993.
20. Saward L, Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81: 249-257, 1997.
21. Saward L, Zahradka P. The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells. J Mol Cell Cardiol 28: 499-506, 1996.
22. Saward L, Zahradka P. Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. Mol Cell Biochem 176: 53-59, 1997.
23. Tian Y, Balla T, Baukal AJ, Catt KJ. Growth responses to angiotensin II in bovine adrenal glomerulosa cells. Am J Physiol Endocrinol Metab 268: E135-E144, 1995.
24. Wang Q, Bilan PJ, Klip A. Opposite effects of insulin on focal adhesion proteins in 3T3-L1 adipocytes and in cells overexpressing the insulin receptor. Mol Biol Cell 9: 3057-3069, 1998.
25. Widdop RE, Vinh A, Henrion D, Jones ES. Vascular angiotensin AT2 receptors in hypertension and ageing. Clin Exp Pharmacol Physiol 35: 386-390, 2008.
26. Wilson DP, Saward L, Zahradka P, Cheung PK. Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model. Cardiovasc Res 42: 761-772, 1999.
27. Yamada T, Akishita M, Pollman MJ, Gibbons GH, Dzau VJ, Horiuchi M. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci 63: PL289-PL295, 1998.
28. Zahradka P, Harding G, Litchie B, Thomas S, Werner JP, Wilson DP, Yurkova N. Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP. Am J Physiol Heart Circ Physiol 287: H2861-H2870, 2004.
29. Zahradka P, Storie B, Wright B. IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II. Can J Physiol Pharmacol 87: 805-812, 2009.
30. Zahradka P, Werner JP, Buhay S, Litchie B, Helwer G, Thomas S. NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. J Mol Cell Cardiol 34: 1609-1621, 2002.
31. Zahradka P, Yau L, Lalonde C, Buchko J, Thomas S, Werner J, Nguyen M, Saward L. Modulation of the vascular smooth muscle angiotensin subtype 2 (AT2) receptor by angiotensin II. Biochem Biophys Res Commun 252: 476-480, 1998.